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Sub-lethal concentrationAbstract Emergence of antibiotic resistance has become an increasingly important public health
issue. Although several new antibiotics have been developed in the last few decades, none of them
show improved activity against multidrug-resistant bacteria. Silver nanoparticles (AgNPs) have
long been known for their broad-spectrum antibacterial effects. The development of a rapid,
dependable, simple, cost-effective, biocompatible, and environmentally friendly method to synthe-
size nanoparticles is an essential aspect of current biomedical research. This paper describes the
extracellular biochemical synthesis of AgNPs using supernatants from Bacillus cereus cultures
and characterization of the synthesized AgNPs, using several analytical techniques. The nanopar-
ticles showed a maximum absorbance at 420 nm in ultraviolet–visible spectra. Particle size analysis
by dynamic light scattering and transmission electron microscopy revealed the formation of homo-
geneous and well-dispersed nanoparticles with an average size of 10 nm. We investigated the dose-
dependent antibacterial activity of AgNPs against Escherichia fergusonii and Streptococcus mutans.
In addition, the efﬁciency of AgNPs with various broad-spectrum antibiotics against these test
strains was evaluated. The results show that the combination of antibiotics with AgNPs has signif-
icant antimicrobial effects. The greatest enhancement was observed with gentamycin and vancomy-
cin against E. fergusonii and S. mutans, respectively. This work supports that AgNPs can be used to
enhance the activity of existing antibiotics against Gram-negative and Gram-positive bacteria.
ª 2014 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Recently, precision-engineered nanomaterials have received
considerable attention for the development of novel therapeu-
tic and diagnostic modalities for human use (Chen and
Schluesener, 2008; Sriram et al., 2010). Silver nanoparticles
(AgNPs) have become increasingly popular as antibiotic
agents in textiles, wound dressings, medical devices, andcherichia
2 S. Gurunathanappliances such as refrigerators and washing machines
(Stensberg et al., 2011). Owing to their unique physical and
chemical properties, as well as their important applications,
AgNPs have received much interest in several areas of
research, including optics, electronics, magnetics, mechanics,
catalysis, energy science, nanobiotechnology, and nanomedi-
cine, particularly as an antimicrobial agent for diagnostic pur-
poses (Stensberg et al., 2011). AgNPs present well-known
antimicrobial activities (Kim et al., 2007; Shahverdi et al.,
2007) and are extensively used in different areas such as for
the production of clothing, catheters, electric home appliances,
and biomedical implants (Matsumura et al., 2003). Because of
their well-known antiseptic activities, distinct silver com-
pounds have been clinically used to reduce skin infections in
the treatment of burns (e.g., silver sulfadiazine) and as coatings
on various surfaces such as catheters (Matsumura et al., 2003;
Chen and Schluesener, 2008).
The development of a simple, cost-effective, reliable, bio-
compatible, and environmentally compatible chemical
approach for the synthesis of nanomaterials is an important
aspect of nanotechnology (Gurunathan et al., 2009, 2014).
There is a growing need to develop an environmentally
friendly nanoparticle synthesis process that does not use toxic
chemicals. The conventional physical methods typically yield
low amounts of AgNPs, and chemical methods are considered
to be toxic and consume a lot of energy. Therefore, the devel-
opment of a toxic-free method for synthesizing metallic nano-
particles is an inevitable process in the ﬁeld of nanotechnology.
Furthermore, capping agents are important for the stabiliza-
tion of nanoparticles. Capped AgNPs exhibit better antibacte-
rial activity compared to uncapped AgNPs (Abdel-Mohsen
et al., 2013; Gnanadhas et al., 2013). In addition, biologically
prepared nanomaterials have tremendous potential because
nanoparticles can easily be coated with a lipid/protein layer
that confers physiological solubility and stability, which are
critical for biomedical applications and are the bottleneck of
other synthesis methods (Emerich and Thanos, 2006).
The use of microorganisms as environmentally friendly pro-
cessors for the synthesis of nanoparticles such as silver or gold
has recently gained a lot of attention. Bacteria and fungi now
play an important role in the remediation of toxic metals
through the reduction of metal ions (Fortin and Bveridge,
2000). Pseudomonas stutzeri is particularly resistant to silver,
and this property is attributed to the intracellular accumula-
tion of silver crystals of approximately 200 nm in diameter
and of a well-deﬁned composition and shape (Klaus et al.,
1999). The natural resources available for ecofriendly synthesis
of nanoparticles are plants, plant products, bacteria, fungi,
algae, yeast, and viruses (Thakkar et al., 2010). Although there
is a large platform for the green synthesis of nanoparticles, the
most commonly preferred way is through bacterial synthesis,
as bacteria are relatively easy to grow and genetically manipu-
late (Parikh et al., 2008).
AgNPs display potent antibacterial and bactericidal prop-
erties not only against Gram-positive and Gram-negative bac-
teria, but also against methicillin-resistant strains (Shahverdi
et al., 2007). AgNPs present antibacterial and anti-bioﬁlm
activities (Kalishwaralal et al., 2010a) and exhibit synergistic
activity with different classes of antibiotics such as b-lactams,
lincosamides, and macrolides (Panacek et al., 2006). Gram-
negative and Gram-positive bacteria are important causes of
various infections, particularly in hospitals, and are resistantPlease cite this article in press as: Gurunathan, S. Rapid biological synthesis of s
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resistance has been observed with all major classes of antibiot-
ics used to treat a wide variety of respiratory illnesses, skin dis-
orders, and sexually transmitted diseases (Criswell, 2004). Due
to the predominance and increase in microorganisms resistant
to multiple antibiotics and rising healthcare costs, many
researchers are interested in developing new and efﬁcacious
antimicrobial reagents that are resistance-free and cost-effec-
tive (Fayaz et al., 2010). Such challenges and needs have led
to a resurgence in the use of silver-based antiseptics that may
be linked to their broad-spectrum activity and far lower pro-
pensity to induce microbial resistance than antibiotics (Jones
et al., 2004).
The ﬁrst aim of this study was to develop a simple, cost-
effective, biocompatible, and ecofriendly approach for the
extracellular biological synthesis of AgNPs using Bacillus cer-
eus. The second aim of our study involved the systematic anal-
ysis of the antibacterial activity of the biologically prepared
AgNPs against Escherichia fergusonii and Streptococcus
mutans. We also investigated the effect of the combination of
antibiotics with AgNPs against E. fergusonii and S. mutans.
2. Materials and methods
2.1. Bacterial strains and reagents
Luria–Bertani (LB) agar was purchased from USB Corpora-
tion (Santa Clara, CA, USA). Mueller Hinton Broth (MHB),
Mueller Hinton Agar (MHA), silver nitrate, and crystal violet
were purchased from Sigma–Aldrich (St. Louis, MO, USA).
All other chemicals were purchased from Sigma–Aldrich
unless otherwise stated. The E. fergusonii, B. cereus, and S.
mutans strains used in the present study were from our in-
house culture collections. All three strains were routinely
grown in LB broth or on LB agar at 37 C.
2.2. Isolation and characterization of AgNP-producing bacteria
Soil samples were collected from an agricultural ﬁeld in Coim-
batore, Tamil Nadu, India in sterile Falcon tubes and trans-
ferred to the laboratory under aseptic conditions on ice. The
sample (1 g) was suspended in 100 mL of 50 mM phosphate
buffer (pH 7.0), serially diluted in the same, and plated on
LB agar containing 10 g tryptone, 5 g yeast extract, 10 g/L
NaCl, and 15 g/L agar). The plates were incubated at 37 C
for 2–3 days. After the incubation period, the bacterial colo-
nies were further sub-cultured in the same medium to obtain
pure colonies. The effective synthesizer of AgNPs was isolated
and named GS6. The isolated bacteria were grown routinely in
LB broth.
The characterization of bacteria was carried out as
described previously (Kalimuthu et al., 2008). The morpholog-
ical and physiological characterization was performed accord-
ing to the methods described in Bergey’s Manual of
Determinative Bacteriology. Further characterization was car-
ried out using the 16s rRNA technique. The sequences have
been submitted to Genbank under accession number
KF944447.
2.3. Bacterial strains and growth conditions
Bacterial growth and media preparation were carried out
according to a method described previously (Gurunathanilver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
x.doi.org/10.1016/j.arabjc.2014.11.014
Table 1 Determination of MIC and sub-lethal concentration of antibiotics and AgNPs.
Bacterial species Amp Chl Ery Gent Tet Van AgNPs
MIC of various antibiotics and AgNPs (lg/mL)
E. fergusonii 2.0 3.0 2.0 1.0 3.0 16.0 7.5
S. mutans 3.0 6.0 4.0 3.0 5.0 7.0 9.5
Sub lethal concentration of antibiotics and AgNPs (lg/mL)
E. fergusonii 1.0 1.25 1.0 0.5 0.75 8.0 1.0
S. mutans 1.5 2.0 1.5 1.0 1.5 4.0 1.0
Biological synthesis of silver nanoparticles 3et al., 2009). Brieﬂy, B. cereus cultures were ﬁrst grown aerobi-
cally at 37 C in LB media. The cultures were maintained by
streaking a colony on LB agar plates and sub-cultured every
fortnight. Pure colonies were isolated and stored at 80 C.
The cells were harvested by centrifugation at 6000 rpm for
10 min, and resuspended in sterile LB medium to obtain an
optical density at 600 nm (OD600) of 1.0.
2.4. Synthesis and characterization of AgNPs
Typically, a 1-liter overnight shaker-culture of B. cereus with a
cell density of 3–4 · 109/mL corresponded to a pellet wet
weight of approximately 3 g/L grown aerobically. A working
concentration of bacterial cells (diluted to OD600 of 1.0) was
inoculated in 50 mL of LB broth and the ﬂasks were incubated
for 24 h (37 C, 200 rpm) under aerobic conditions. After incu-
bation, the culture was centrifuged (10,000 rpm, 10 min) and
the supernatant was used for the synthesis of AgNPs. The cul-
ture supernatant was mixed with an aqueous solution of 1 mM
AgNO3 solution and kept at 40 C for 60 min. The production
yield of AgNPs was calculated according to a previously
described method (Kalishwaralal et al., 2010b), and diluted
to a ﬁnal concentration of 1 mg/mL. The conversion efﬁcien-
cies of these bacterial strains were consistent with a previous
report.
The synthesized particles were characterized according to a
previously described method (Gurunathan et al., 2009). UV–
vis spectra were recorded using a Biochrom WPA Biowave
II UV/Visible Spectrophotometer (Biochrom, Cambridge,
UK). The particle sizes were measured by dynamic light scat-
tering (DLS) using a Zetasizer Nano ZS90 (Malvern Instru-
ments, Malvern, UK). X-ray diffraction (XRD) analyses
were carried out on an X-ray diffractometer (Bruker D8 DIS-
COVER, Bruker AXS GmBH, Karlsruhe, Germany). The
high-resolution XRD patterns were measured at 3 Kw with
Cu target using a scintillation counter. (k= 1.5406 A˚) at
40 kV and 40 mA were recorded in the range of 2h= 5–50.
Further characterization of changes in the surface and surface
composition was performed by Fourier transform infrared
spectroscopy (FT-IR) (PerkinElmer Spectroscopy GX, Perkin-
Elmer, Waltham, MA, USA). Transmission electron micros-
copy (TEM; JEM-1200EX) was used to determine the size
and morphology of AgNPs. TEM images were obtained at
an accelerating voltage of 300 kV.
2.5. Determination of the minimum inhibitory concentration
(MIC) and sublethal concentration of antibiotics and AgNPs
Susceptibility tests with AgNPs and various antibiotics were
carried out in 96-well microtiter plates using a standard 2-fold
broth microdilution of the antibacterial agents in MHB,Please cite this article in press as: Gurunathan, S. Rapid biological synthesis of si
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(CLSI) guidelines (CLSI, 2005). To examine AgNP MICs, E.
fergusonii and S. mutans were exposed to 0–10 lg/mL AgNPs
prepared in phosphate-buffered saline (PBS). The appropriate
concentration of AgNP solution and 1 mL of the bacterial sus-
pension were mixed in MH media to a ﬁnal bacterial concen-
tration of 105–106 colony forming units (CFUs)/mL for 24 h.
After the treatment, 100 lL of the reaction mixture was diluted
10-fold, 100 lL of which was used for plating on agar-contain-
ing media. The loss of viability was evaluated by the colony-
counting method and compared with those on control plates,
which consisted of MH media without AgNP-based materials.
All treatments were prepared in triplicate, and performed in at
least three independent experiments. The MIC was determined
as the lowest concentration that inhibited the visible growth of
the bacteria (Table 1). Control tests were carried out with solu-
tions containing all the reaction components with the excep-
tion of AgNPs. Antibiotic or AgNP concentrations that
reduced the number of susceptible cells by less than 20% after
4 h of incubation were designated as sub-lethal (Minahk et al.,
2004). In addition, viability assays were carried out with
different concentrations of antibiotics alone, AgNPs alone,
or a combination of sub-lethal concentrations of antibiotics
and AgNPs.
2.6. Antimicrobial activity of antibiotics and AgNPs against E.
fergusonii and S. mutans
The assessment of AgNPs’ microbial toxicity was performed
according to a previously described method (Shahverdi et al.,
2007; Kora and Rastogi, 2013). To examine the effect of
AgNPs on the growth of E. fergusonii and S. mutans, the over-
night cultures were centrifuged at 6000 rpm for 5 min, washed
with PBS (1·), and the pellet was resuspended in PBS. Finally,
the OD600 of the sample was adjusted to 0.1. The cells
(5 · 105 bacteria/well in 96-well round bottom plates in tripli-
cate) were then exposed to different concentrations of AgNPs.
Bacteria were harvested at the indicated time points or dose
responses, and the number of CFUs was assayed. Medium
or medium with AgNPs served as controls. All samples were
plated in triplicate and values were averaged from three
independent experiments.
2.7. Agar diffusion assay
The agar diffusion assay was performed as described previ-
ously (Shahverdi et al., 2007; Kora and Rastogi, 2013). In gen-
eral, the agar diffusion method is used to assay various
antibiotics for their bactericidal activity against test strains
on MHA plates. In our experiment, we evaluated the antibac-
terial activity of antibiotics in combination with or withoutlver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
x.doi.org/10.1016/j.arabjc.2014.11.014
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otics to analyze the combined effect of antibiotics and AgNPs.
Based on the CLSI standard, antibiotics were used at selected
concentrations as follows: ampicillin (10 lg/mL), chloram-
phenicol (30 lg/mL), erythromycin (15 lg/mL), gentamicin
(10 lg/mL), tetracycline (30 lg/mL), and vancomycin (30 lg/
mL). To determine the combined effects, each standard paper
disk was further impregnated with the MIC of AgNPs for each
bacterial strain. A single colony of each test strain was grown
overnight in MHB on a rotary shaker (200 rpm) at 37 C. The
inocula were prepared by diluting the overnight cultures with
0.9% NaCl to a 0.5 McFarland standard and were applied
to the plates along with the standard and prepared disks con-
taining different antibiotics. Similar experiments were carried
out with AgNPs alone. After incubation at 37 C for 24 h, a
zone of inhibition (ZOI) was measured by subtracting the disk
diameter from the total inhibition zone. The assays were per-
formed in triplicate. The increase in antibacterial activity of
different antibiotics was quantiﬁed by the equation (B  A)/
A · 100, where A and B are the ZOI for antibiotic and antibi-
otic + AgNPs, respectively (Kora and Rastogi, 2013).
2.8. In vitro killing assays
In vitro killing assays were performed as described previously
(Mohanty et al., 2012; Morones-Ramirez et al., 2013) with
suitable modiﬁcations. Cells were grown overnight in MHB
broth at 37 C and regrown in fresh medium for 4 h before
being collected by centrifugation and suspended in deionized
water, which was used because it lacks the chloride ions that
are present in PBS that would interfere with silver (Morones-
Ramirez et al., 2013). A cell suspension consisting of 106 -
cells/mL was incubated with various concentrations of antibi-
otics, AgNPs, or combinations of AgNPs with the respective
antibiotics for 4 h at 37 C. After incubation, bacteria were
harvested at the indicated time points and 100-lL aliquots
were taken from each sample to determine CFUs. The experi-
ment was performed with various controls, including a positive
control (AgNPs and MHB media without inoculum) and a
negative control (MHB and inoculum without AgNPs). All
samples were plated in triplicate, and values were averaged
from three independent experiments.
2.9. Measurement of protein leakage
Protein leakage from bacterial cells was determined as
described previously (Kim et al., 2011). The concentration of
AgNPs or antibiotics was adjusted to the sub-lethal concentra-
tion for each bacterial strain and the concentration of bacterial
cells was adjusted to 106 CFUs/mL. Each culture was incu-
bated in a shaking incubator at 37 C for 4 h. One milliliter
of sample was obtained from each culture, centrifuged at
4 C for 30 min at 300·g, and the supernatant was frozen at
20 C until assay. Protein concentrations in the supernatants
were determined by the Bradford assay and the OD was mea-
sured at 595 nm.
2.10. Measurement of reactive oxygen species (ROS)
generation
Quantitative assays for superoxide anions were carried out using
a (sodium 2,3,-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyla-
mino)-carbonyl]-2H-tetrazolium inner salt (XTT)-based in vitroPlease cite this article in press as: Gurunathan, S. Rapid biological synthesis of s
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manufacturer’s instructions. E. fergusonii and S. mutans were
grown in MHB medium and cells were washed with PBS buffer
and resuspended in PBS at a concentration of 2 · 106 viable cells
(determined as CFUs) per mL. XTT was added to the cell sus-
pension at a concentration of 125 lM from a stock solution
(7.5 mM) prepared in PBS. Cell suspensions were incubated at
30 C on a rotary shaker for 12 h, aliquots were spun in a micro-
fuge, and the absorbance of the supernatant was measured at
450 nm. XTT reduction in the absence of cells was always deter-
mined as a control and subtracted from the values observed in
the presence of cells.
2.11. Measurement of malondialdehyde (MDA)
The concentration of MDA generated in the culture media was
determined using a thiobarbituric acid reactive substances
assay as described previously (Dutta et al., 2012) with suitable
modiﬁcations. Brieﬂy, an aliquot of 1 mL of culture media was
collected from the AgNP-treated cells and 10% SDS was
added and swirled vigorously. Further, 2 mL of freshly pre-
pared thiobarbituric acid (TBA) was added to the above mix
and incubated at 95 C for 60 min. The reaction was then
cooled to room temperature and centrifuged at 5000 rpm for
10 min, and the OD of the supernatant was measured at
530 nm.
2.12. Statistical analysis
All the experiments were performed in triplicate and repeated
at least three times. The results are presented as means ± SD.
All experimental data were compared using the Student’s t-
test. A p-value less than 0.05 was considered statistically
signiﬁcant.
3. Results and discussion
3.1. Synthesis and characterization of AgNPs using supernatant
from B. cereus culture
The AgNPs were synthesized using supernatants from B. cer-
eus cultured with AgNO3. The appearance of a yellowish-
brown color in the AgNO3-treated culture supernatant sug-
gested the formation of AgNPs (Fig. 1A) (Shahverdi et al.,
2007; Kalimuthu et al., 2008; Gurunathan et al., 2009). The
initial pH of the culture supernatant was 6.0, which was
adjusted to pH 8.0 with NaOH. The slightly alkaline pH
increases the synthesis reaction rate as well as favoring synthe-
sis of smaller-sized nanoparticles (Gurunathan et al., 2009).
The synthesis was rapid and completed within 60 min. We pre-
viously synthesized AgNPs using various bacteria, for exam-
ple, Bacillus licheniformis (Kalimuthu et al., 2008),
Brevibacterium casei (Kaliswaralal et al., 2010a,b), Escherichia
coli (Gurunathan et al., 2009), etc., and all these bacterial
strains produced AgNPs within 24 h of incubation. In con-
trast, B. cereus produces AgNPs within 1 h of incubation,
the speed of which is attributed to the type of capping agent
produced by these bacteria and also it depends on type of
strain.
AgNPs were further characterized using ultraviolet–visible
spectroscopy, and an intense, broad absorption peak was
observed at 420 nm (Fig. 1B), which was assigned to surfaceilver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
x.doi.org/10.1016/j.arabjc.2014.11.014
Figure 1 Synthesis and characterization of AgNPs using supernatant of B. cereus culture. (A) Synthesis of AgNPs using B. cereus culture
supernatant. The image shows vials with samples of AgNO3 (1), culture supernatant (2), and AgNO3 with the culture supernatant (3).
After incubation for 60 min, the color of the solution turned from colorless to brown, indicating the formation of AgNPs. (B) Ultraviolet–
visible spectrum of AgNPs. The absorption spectrum of AgNPs exhibited an intense, broad peak at 420 nm. The observation of this band
was attributed to surface plasmon resonance of the AgNPs particles.
Biological synthesis of silver nanoparticles 5plasmon resonance and is well documented for various metal-
lic nanoparticles with sizes ranging from 2 nm to 100 nm
(Henglein, 1993; Kowshik et al., 2003). The synthesis could
be mediated by the enzyme nitrate reductase, as suggested by
results obtained for B. licheniformis (Kalimuthu et al., 2008).
Several methods for AgNPs synthesis and formulation have
been described previously. For example, conventional physical
and chemical methods have been used for the synthesis of
AgNPs such as reduction of silver ions. However, the yields
were low, the control of the particle size is difﬁcult, and these
methods are environmentally incompatible due to the use of
toxic chemical reducing agents such as citrate, borohydride,
or other organic compounds (Wani and Ahmad, 2013a;
Wani et al. 2013b). Moreover, the chemical synthesis of nano-
particles requires an additional step to prevent the aggregation
of the particles, whereas in the biological method, the proteins
present in the media function as stabilizers and prevent aggre-
gation. In addition, the size and shape of the particles can be
controlled by pH and temperature (Gurunathan et al., 2009).
Since particle size and shape is an important factor in various
biomedical applications, biologically based methods are envi-
ronmentally friendly alternatives for the synthesis of AgNPs
with deﬁned particle size and monodispersity. Using the
proper growth medium, synthesis conditions, pH, substrate
concentrations, temperature, and reaction time, it might be
possible to obtain sufﬁcient amounts of AgNPs (Gurunathan
et al., 2009).
Earlier studies have proposed mechanisms for synthesis of
silver nanoparticles using bacteria. Butler et al. (2004) demon-
strated that MacA is an inner membrane-bound c-type cyto-
chrome that is located in the periplasm and is proposed to
transfer electrons from the inner membrane to the periplasm.
It has been shown to be important in the reduction of Fe(III)
citrate and U(VI) (Slawson et al., 1992, 1994), both of which
could potentially enter the periplasm. MacA could also be
involved in electron transfer to outer-membrane cytochromes,
including those on the surface of the cell, where the Ag(0) was
found to accumulate in these experiments. OmcF is an outer
membrane c-type cytochrome and is thought to play a rolePlease cite this article in press as: Gurunathan, S. Rapid biological synthesis of si
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et al., 2005). For example, Geobacter sulfurreducens reduces
Ag(I) (as insoluble AgCl or Ag+ ions), via a mechanism
involving c-type cytochromes, resulting in precipitation of
extracellular nanoscale Ag(0). Further, Law et al. (2008) have
suggested a role for an electron transfer chain traversing the
periplasm and the outer membrane, consistent with the extra-
cellular localization of reduced Ag(0) nanoparticles.
Kalimuthu et al. (2008) reported that this reduction may occur
via electron transfer from NADH, where NADH-dependent
reductase can act as a carrier in B. licheniformis. In our case,
an analogous phenomenon might happen in B. cereus in which
nitrate reductase is present on the membrane.
3.2. X-ray diffraction analysis of AgNPs
X-ray diffraction (XRD) was employed to conﬁrm the crystal-
line nature of the particles, and the XRD displayed numbers of
Braggs reﬂections that may be indexed on the basis of the face-
centered cubic structure of silver (Shahverdi et al., 2007;
Matsumura et al., 2003; Kalishwaralal et al., 2010a;
Gurunathan et al., 2014). A comparison between the XRD
spectra of AgNPs and the standard conﬁrmed that the silver
particles formed in our experiments were in the form of nano-
crystals, as evidenced by the peaks at 2h values of 31.9, and
45.58, corresponding to (111), and (200), respectively, Bragg
reﬂections of silver (Fig. 2). The assigned peaks at 2h values
of 29.8 (*) may be related to crystalline and amorphous
organic phases, respectively. The X-ray diffraction results
clearly show that the AgNPs formed by the reduction of
Ag+ ions in the culture supernatant of B. cereus are crystalline
in nature.
3.3. FTIR analysis of AgNPs
FTIR spectroscopy was performed to conﬁrm that the culture
supernatant of B. cereus has the ability to perform the dual
functions of reduction of Ag+ to Ago, and stabilization oflver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
x.doi.org/10.1016/j.arabjc.2014.11.014
Figure 2 XRD pattern of AgNPs synthesized in the supernatant
of B. cereus.
Figure 3 FTIR spectra of AgNPs synthesized by the supernatant
of B. cereus.
6 S. GurunathanAgNPs. The FTIR spectra of culture supernatant-derived
AgNPs shows a broad and intense band at 3400 cm1, which
is due to bound hydroxyl (–OH) or amine (–NH) groups found
in the proteins of the culture supernatant. Shoulder peaks at
1600 cm1 and 1550 cm1 indicate that the amide I and amide
II arise due to carbonyl and –NH stretch vibrations in the
amide linkages of the proteins, respectively. The band at
1380 cm1 corresponds to C‚C stretching of aromatic amine
(Fig. 3). FTIR bands of biologically synthesized silver
nanoparticles, conﬁrms the presence of protein in the silver
nanoparticles, which further conﬁrm that biosynthesized
AgNPs coated with biological molecules. This study further
proves that capping protein stabilizes AgNPs and prevents
agglomeration of AgNPs (Gurunathan et al., 2009, 2014;
Thakkar et al., 2010; Parikh et al., 2008). Thus, these FTIR
data conﬁrm the presence of protein in the biologically synthe-
sized AgNPs.
3.4. Size and shape analysis of AgNPs
The physical characterization of nanoparticles in solution is
essential before assessing their in vitro toxicity (Murdock
et al., 2008). Particle size, size distribution, morphology,
composition, surface area, surface chemistry, and reactivityPlease cite this article in press as: Gurunathan, S. Rapid biological synthesis of s
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nanoparticle toxicity (Murdock et al., 2008). Powers et al.
(2006) suggested that DLS is a powerful technique for evaluat-
ing particle size, size distribution, and the zeta potential of
nanomaterials in solution. DLS measurements were performed
in aqueous solution to elucidate the size of AgNPs synthesized
by B. cereus. It was found that the average hydrodynamic
diameter of AgNPs was 10 nm. Fig. 4A shows that the parti-
cles synthesized by B. cereus presented sizes ranging from
2 nm to 20 nm, with an average size of 10 nm.
Next, we examined the size of the synthesized AgNPs using
TEM. TEM micrographs showed that well-dispersed particles
were signiﬁcantly spherical in shape (Fig. 4B) and the particle
size ranged from 2 nm to 16 nm, with an average size of 10 nm
(Fig. 4C). Several studies reported the use of a biological sys-
tem for the synthesis of AgNPs using supernatant from Kleb-
siella pneumoniae, B. licheniformis, and E. coli cultures, in
which the particles had an average size of 52.5, 40, and
50 nm, respectively (Shahverdi et al., 2007; Gurunathan
et al., 2009; Kalimuthu et al., 2008). When the spore-crystal
mixture of Bacillus thuringiensis was used for synthesis of
AgNPs, the average size of AgNPs was 15 nm, which was con-
ﬁrmed by TEM, and the structure was cubic and hexagonal.
Taken together with these previous reports, our FTIR, DLS,
and TEM data suggest that capping protein stabilizes AgNPs
and prevents their aggregation.
3.5. Determination of MIC and sub-lethal concentration of
antibiotics and AgNPs
The following experiments were performed to determine the
lowest concentration that completely inhibits the visible
growth of bacteria. According to previous studies, AgNPs
exhibit potent antibacterial effects, particularly against
Gram-negative bacteria (Kim et al., 2007; Shahverdi et al.,
2007). We were interested to study the antibacterial activity
of AgNPs with inhibitory concentrations and also to evaluate
the enhanced effect of biologically synthesized AgNPs with
antibiotics using sub-lethal concentrations on Gram-negative
and Gram-positive bacteria. To examine the antimicrobial
activity of the AgNPs alone or in combination with ampicillin,
chloramphenicol, erythromycin, gentamycin, tetracycline, and
vancomycin, antibacterial susceptibility testing was conducted
against E. fergusonii and S. mutans. As shown in Table 1,
AgNPs exhibited antibacterial activity against E. fergusonii
and S. mutans with MIC values of 7.5 lg/mL and 9.5 lg/mL,
respectively. In general, AgNPs are more potent against
Gram-negative than Gram-positive bacteria. The bacterial
strains showed MIC values of 2–3 lg/mL for ampicillin, 3–
6 lg/mL for chloramphenicol, 2–4 lg/mL for erythromycin,
1–3 lg/mL for gentamycin, 3–5 lg/mL for tetracycline, and
7–16 lg/mL for vancomycin (Table 1). AgNPs and the antibi-
otics showed diverse degrees of antibacterial activity in relation
to the bacterial species used in this study. E. fergusonii tended
to be more sensitive to gentamycin than S. mutans. Conversely,
S. mutans tended to be more sensitive to vancomycin than E.
fergusonii. Hwang et al. (2012) reported that Gram-negative
and Gram-positive bacterial strains showed MIC values of
0.25–2.0 lg/mL for AgNPs, 2–8 lg/mL for ampicillin, 1–
4 lg/mL for chloramphenicol, and 2–4 lg/mL for kanamycin.
However, the AgNPs and antibiotics showed different degreesilver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
x.doi.org/10.1016/j.arabjc.2014.11.014
Figure 4 Determination of size and shape of AgNPs. (A) The particle-size distribution revealed that the particles ranged in size from 2 to
20 nm, with an average size of 10 nm. (B) The size and morphology of AgNPs were analyzed using TEM, which conﬁrmed an average
particle size of 10 nm. (C) Percentage of particle size distribution based on TEM images.
Figure 5 Effect of AgNPs on cell survival of E. fergusonii and S.
mutans. All the test strains were incubated in the presence of
different concentrations of AgNPs. Bacterial survival was deter-
mined at 4 h by a CFU count assay. The experiment included a
positive control (AgNPs and MHB media, without inoculum) and
a negative control (MHB and inoculum, without AgNPs). The
results are expressed as the means ± SD of three separate
experiments, each of which contained three replicates. Treated
groups showed statistically signiﬁcant differences from the control
group by the Student’s t-test (p< 0.05).
Biological synthesis of silver nanoparticles 7of antibacterial activity in relation to the bacterial species. The
results drawn from the present study suggest that the MICs of
AgNPs synthesized from B. cereus against E. fergusonii and
S. mutans are signiﬁcantly lower than previously reported.
The MICs of poly-(N-vinyl-2-pyrrolidone)-stabilized AgNPs
against Staphylococcus aureus and E. coli are 50 and 100 lg/
mL, respectively (Cho et al., 2005). Rafﬁ et al. (2008) reported
that AgNPs (mean size 16 nm) synthesized using an inert gas
condensation method were effective bactericides against
E. coli at concentrations P60 lg/mL.
3.6. Dose-dependent antibacterial effect of AgNPs in E.
fergusonii and S. mutans
The dose-dependent effect of AgNPs was assessed in represen-
tative Gram-positive and Gram-negative bacterial strains that
were used to assess the relative susceptibility to AgNPs and the
extent of bactericidal activity of AgNPs. Fig. 5 shows the
potential toxic effect of biologically synthesized AgNPs on
E. fergusonii and S. mutans. The bacterial strains were treated
with various concentrations of 10-nm AgNPs at 1–10 lg/mL.
The results show that the introduction of AgNPs affected the
cell viability as compared to the negative control. Further-
more, cell viability decreased with increasing AgNP concentra-
tion. As determined in the MIC experiment, at their respectivePlease cite this article in press as: Gurunathan, S. Rapid biological synthesis of silver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
fergusonii and Streptococcus mutans. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014.11.014
Figure 6 Enhancement of antibacterial activity of antibiotics in
the presence of AgNPs. The antibacterial activity of AgNPs was
evaluated using the agar diffusion method. The MICs of AgNPs
for each test strain were loaded into the wells formed on plates
containing a layer of bacteria. Growth inhibition was determined
by measuring the zone of inhibition after 24 h. Experiments were
performed in triplicate. The percentage of enhancement in
antibacterial activity was calculated using the formula (B  A/
A) · 100. The results are expressed as the means ± SD of three
separate experiments, each of which contained three replicates.
Treated groups showed statistically signiﬁcant differences from the
control group by the Student’s t-test (p< 0.05).
8 S. GurunathanMIC values, no visible bacterial growth was observed above
7.5 lg/mL and 10 lg/mL in E. fergusonii and S. mutans
cultures, respectively (Table 1). In the case of E. fergusonii,
the introduction of 7.5 lg/mL of AgNPs reduced bacterial cell
density by approximately 99% as compared to the control
sample. Furthermore, increasing the concentration of AgNPs
to 8 lg/mL and 10 lg/mL inhibited bacterial growth, as these
concentrations represent MIC values. Interestingly, for S.
mutans, the introduction of a similar concentration of AgNPs
(i.e., 7.5 lg/mL) reduced cell viability by approximately 75%
as compared to the control sample. However, the higher con-
centrations of 8 lg/mL and 10 lg/mL rapidly inhibited the
growth of bacteria (Fig. 5). Nevertheless, the speciﬁc mecha-
nism of the antibacterial effect of AgNPs against bacteria
remains unknown. AgNPs may pass through the cell wall of
bacteria to oxidize the surface proteins on the plasma mem-
brane and consequently disturb cellular homeostasis (Sondi
and Salopek-Sondi, 2004). Several research groups have sug-
gested that AgNPs may attach to the surface of the cell and
alter its permeability or disrupt metabolic functions such as
respiration (Chauhan et al., 2013; Murray et al., 1965). Our
results suggest that AgNPs produced using a biological
method are smaller in size compared to chemically synthesized
AgNPs, which may provide more bactericidal effects than lar-
ger particles, as the cellular uptake of particles tends to be
inversely correlated with size.
Similarly, Li et al. (2010) reported that 10 lg/mL AgNPs
could completely inhibit the growth of 107 CFUs/mL of
E. coli in liquid MHB. They also suggested that the mechanism
of antibacterial activity involved leakage of reduced sugars and
proteins, and induced the respiratory chain dehydrogenases.
AgNPs were also evaluated for use in combination with differ-
ent antibiotics against S. aureus and E. coli, and were shown to
increase the antimicrobial activities of these antibiotics
(Shahverdi et al., 2007). Guzma´n et al., 2009 demonstrated
that AgNPs showed high antimicrobial and bactericidal
activity against Gram-negative bacteria such as E. coli,
Pseudomonas aeruginosa, than S. aureus. Similarly, our results
also suggest that AgNPs show strong antibacterial activity
against Gram-negative and Gram-positive bacteria.
3.7. AgNPs enhance the antibacterial effects of antibiotics
We analyzed whether the combination of antibiotics with
AgNPs could increase their antibacterial activity. In this exper-
iment, the combined effect of antibiotics with AgNPs was
assessed using the agar diffusion method in E. fergusonii and
S. mutans. The activity of the six antibiotics tested, ampicillin
(10 lg/mL), chloramphenicol (30 lg/mL), erythromycin
(15 lg/mL), gentamicin (10 lg/mL), tetracycline (30 lg/mL),
and vancomycin (30 lg/mL), with AgNPs showed signiﬁcant
antibacterial effects against both Gram-negative and Gram-
positive bacteria (p< 0.05). Fig. 6 shows that AgNPs
enhanced the antibacterial activity of the antibiotics. The
activity of the tested antibiotics was increased in combination
with AgNPs against the tested bacterial strains. In the case of
E. fergusonii, the highest increase was observed for gentamycin
(p< 0.05) followed by ampicillin, chloramphenicol, erythro-
mycin, tetracycline, and vancomycin (p< 0.05). In the
case of S. mutans, the highest increase was observed for
vancomycin (p< 0.05), followed by ampicillin (p< 0.05),
chloramphenicol (p< 0.05), gentamycin, tetracycline, andPlease cite this article in press as: Gurunathan, S. Rapid biological synthesis of s
fergusonii and Streptococcus mutans. Arabian Journal of Chemistry (2014), http://derythromycin (p< 0.05). Among the selected antibiotics, gen-
tamycin and vancomycin showed the highest percentage of
enhancement of activity against E. fergusonii and S. mutans,
respectively. These results suggested a differential susceptibility
between Gram-negative and Gram-positive bacteria toward
the type of antibacterial agents combined with AgNPs, which
may be due to differences in cell-wall composition.
3.8. Enhanced antibacterial effect of antibiotics and AgNPs
Next, we explored the possibility of using AgNPs as an antibi-
otic adjuvant to evaluate the additive potential effect on anti-
biotic susceptibility. We ﬁrst reasoned that Ag+ could
potentiate the bactericidal effect of antibiotics that share a
common mechanism of action involving the overproduction
of ROS (Morones-Ramirez et al., 2013; Kohanski et al.,
2007). The results showed that the highest enhancing effect
was observed for gentamycin against E. fergusonii and for van-
comycin against S. mutans. Therefore, we selected these two
antibiotics to examine the antibacterial activity in Gram-nega-
tive and Gram-positive bacteria, respectively. In this experi-
ment, bacteria in the exponential growth phase were
incubated with sub-lethal concentrations of antibiotics,
AgNPs, or a combination of both. The CFU number was ana-
lyzed by harvesting bacteria at different time points and the
surviving colonies were enumerated after 24 h. CFU assays
showed that sub-lethal concentrations of antibiotics or AgNPs
alone had no signiﬁcant killing effect in both Gram-negative
and Gram-positive bacteria. Compared to untreated controls,
the combination of gentamycin and AgNPs signiﬁcantly inhib-
ited cell viability in E. fergusonii (p< 0.05), by more than 65%
(Fig. 7), whereas gentamycin combined with AgNPs showed a
noticeable effect on S. mutans. In response to vancomycin,
S. mutans exhibited a sharp and signiﬁcant decrease in cellilver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
x.doi.org/10.1016/j.arabjc.2014.11.014
Figure 8 Enhanced effect of antibiotics and AgNPs on protein
leakage. For protein leakage analysis, the Bradford assay was
performed on the media supernatants from cells treated with sub-
lethal concentrations of antibiotics, AgNPs, or combinations of
both for 12 h.
Figure 7 AgNPs increase the bactericidal effect of antibiotics. Upper panel: All test strains were treated with sub-lethal concentrations of
gentamycin, AgNPs, or a combination of AgNPs and gentamycin for 4 h. Lower panel: All test strains were treated with sub-lethal
concentrations of vancomycin, AgNPs or a combination of AgNPs and vancomycin for 4 h. Bacterial survival was determined at 4 h by
CFU assay. The experiment was performed with various controls, including a positive control (AgNPs and MHB media, without
inoculum) and a negative control (MHB and inoculum, without AgNPs). The results are expressed as the means ± SD of three separate
experiments, each of which contained three replicates. Treated groups showed statistically signiﬁcant differences from the control group by
the Student’s t-test (p< 0.05).
Biological synthesis of silver nanoparticles 9viability of approximately 61% (p< 0.05) (Fig. 7), whereas
E. fergusonii showed a noticeable effect with vancomycin.
These results suggest that E. fergusonii and S. mutans are more
susceptible to gentamycin and vancomycin, respectively.
However, the combination of any antibiotic with AgNPs
signiﬁcantly increased the effect on bacterial cell death relative
to treatments with AgNPs or ampicillin alone (p< 0.05).
3.9. Enhanced effect of antibiotics and AgNPs on membrane
protein leakage
AgNPs are known to enhance protein leakage by increasing
the membrane permeability in bacteria. In order to determine
the impact of AgNPs alone or in combination with antibiotics
on protein leakage, the cells were treated with AgNPs alone or
in combination with antibiotics for 12 h. The amount of pro-
tein released in the suspension of the treated cells was esti-
mated using the Bradford assay. When the cells were treated
with a combination of AgNPs and antibiotic, the amount of
protein released from the cells increased compared to treat-
ment with AgNPs or antibiotics alone (Fig. 8). At 12 h after
incubation, protein leakage from cells treated with AgNPs
was considerably increased. However, there was no change
in the amount of protein leakage from cells in the control
group or in the groups treated with antibiotics alone. Leakage
from cells treated with a combination of AgNPs and antibiot-
ics was signiﬁcantly higher than that from cells in the control
group or AgNPs alone group. Leakage from cells treated with
AgNPs was signiﬁcantly increased compared to that from cellsPlease cite this article in press as: Gurunathan, S. Rapid biological synthesis of si
fergusonii and Streptococcus mutans. Arabian Journal of Chemistry (2014), http://din the control group, indicating that AgNPs alone can increase
membrane permeability. Notably, higher amounts of proteins
leaked through Gram-negative bacterial membranes compared
to Gram-positive bacterial membranes, suggesting that the
antibacterial sensitivity of the Gram-positive S. mutans was
lower than that of the Gram-negative E. fergusonii. This differ-
ence may be attributed to the thickness of the peptidoglycanlver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
x.doi.org/10.1016/j.arabjc.2014.11.014
10 S. Gurunathanlayer of Gram-positive bacteria. An essential function of the
peptidoglycan layer is to protect against antibacterial agents
such as antibiotics, toxins, chemicals, and enzymes. This result
is consistent with the results of previous studies (Kim et al.,
2011; Tiwari et al., 2008). Tiwari et al. (2008) showed that pro-
tein released from the cells increased along with increasing
concentration of AgNPs, and that the leakage of proteins in
Bacillus subtilis was lower than that of E. coli. A similar trend
was observed in our experiments, as Gram-negative bacteria
showed higher amounts of protein leakage than Gram-positive
bacteria. Interestingly, the combined effect of antibiotics and
AgNPs exhibited signiﬁcantly higher effects than AgNPs or
antibiotics alone.
3.10. Enhanced effect of antibiotics and AgNPs on MDA and
ROS generation
MDA content was measured in cultures treated with AgNPs,
antibiotics, or the combination of both. It has been shown that
hydroxyl radicals generated in suspensions of AgNPs in cul-
ture media can extract hydrogen from the allylic positions of
unsaturated fatty acids (Dutta et al., 2012). These allylic free
radicals react with O2 to form lipid peroxide radicals (LOO
),
which can then undergo rearrangement to form MDA
(Dutta et al., 2012). Previous studies reported that MDA is
produced during the lipid peroxidation of unsaturated fatty
acids by oxygen-based free radicals, and the amount of
MDA is related to the concentration of generated ROS
(Yagi, 1998; Lefevre et al., 1998; Dutta et al., 2012). As shown
in Fig. 9, compared to the control, the levels of MDA were sig-
niﬁcantly higher and increased further with combinations of
antibiotics and AgNPs (Fig. 9). These results indicate that
the increase in ROS generation is due to AgNPs in the culture
media. It is also noteworthy that the amount of MDA was 3–
4-fold higher with the combination of antibiotics and AgNPs
than AgNPs or antibiotics alone. These results suggest that
the inhibition of bacterial growth due to AgNPs or antibiotics
is attributable to ROS formation. Our results are consistentFigure 9 Enhanced effect of antibiotics and AgNPs on MDA
level. All test strains were treated with sub-lethal concentrations of
antibiotics, AgNPs, or a combination of AgNPs and antibiotics
for 12 h. The quantity of MDA was measured as described in
Section 2. The results are expressed as the means ± SD of three
separate experiments, each of which contained three replicates.
Treated groups showed statistically signiﬁcant differences from the
control group by the Student’s t-test (p< 0.05).
Please cite this article in press as: Gurunathan, S. Rapid biological synthesis of s
fergusonii and Streptococcus mutans. Arabian Journal of Chemistry (2014), http://dwith recent reports on the toxicity of ZnO nanoparticles
toward E. coli (Dutta et al., 2012) and increased apoptosis in
cancer cells induced by lipid peroxidation (Premanathan
et al., 2011). To substantiate that MDA plays an important
role in oxidative stress, we further investigated the generation
of ROS in cells treated with AgNPs, antibiotics, or a combina-
tion of both.
Recently, several studies showed that the application of
lethal doses of bactericidal antibiotics promotes the formation
of highly detrimental ROS (Kim et al., 2007; Kohanski et al.,
2007; Dwyer et al., 2012) which is one of the key mechanisms
of toxicity. The mechanisms of cell death, oxidative stress, and
ROS formation were shown to be some of the key mechanisms
in cellular defense after particle uptake. Intracellular oxidative
stress could be hastened by NPs through disturbing the equi-
librium between oxidative and reductive processes (Nel et al.,
2006). Thus, we investigated the effect of sub-lethal concentra-
tions of antibiotics, AgNPs, or combinations of antibiotics and
AgNPs on the formation of ROS in E. fergusonii and S.
mutans. The ROS levels in antibiotic- or AgNP-treated cells
were lower than that in cells treated with a combination of
antibiotics and AgNPs (Fig. 10). Elevated ROS and free radi-
cal levels are candidate mediators for cell death. The produc-
tion of ROS could be caused by an impeded electronic
transport along the respiratory chain in the damaged plasma
membrane (Su et al., 2009).
Taken together, these results indicate that cell death is med-
iated by ROS production, which might alter the cellular redox
status. In general, the cellular uptake of smaller nanoparticles
is more efﬁcient than that of larger particles. Some studies sug-
gest that, in addition to the uptake of greater numbers, the
higher cytotoxicity of smaller particles compared to larger ones
is related to the amount of ROS generated on the relatively lar-
ger surface area of small nanoparticles (Carlson et al., 2008).
The precise mechanism by which AgNPs exert their bacterici-
dal effect remains unclear. Guzma´n et al., 2009 proposed that
AgNPs may attach to the surface of the cell membrane and
alter its permeability or disturb metabolic functions such as
respiration, and suggested that the binding of the particles to
the bacteria depends on the surface area available for interac-
tion. Smaller particles, having a larger surface area availableFigure 10 Enhanced effect of antibiotics and AgNPs on ROS
generation. ROS generation was measured by an XTT assay. The
results are expressed as the means ± SD of three separate
experiments, each of which contained three replicates. Treated
groups showed statistically signiﬁcant differences from the control
group by the Student’s t-test (p< 0.05).
ilver nanoparticles and their enhanced antibacterial eﬀects against Escherichia
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Biological synthesis of silver nanoparticles 11for interaction, would have a greater bactericidal effect than
larger particles (Guzma´n et al., 2009; Carlson et al., 2008).
Taken together with previous studies, the results presented
here suggest that smaller-sized nanoparticles are more cyto-
toxic than larger particles.
Silver ions are very reactive and are known to bind to var-
ious vital components of cells and induce processes that initiate
cell death. Silver ions exhibit their antimicrobial functions via
binding to negatively charged DNA and to thiol-containing
proteins, thereby inhibiting protein function. Finally, the
induction of ROS synthesis leads to the formation of highly
reactive cytotoxic free radicals (Matsumura et al., 2003;
Pandian et al., 2010). However, the mechanism of action of
AgNPs is not yet clearly understood. It has been reported that
the mode of antibacterial action of AgNPs is probably similar
to that of silver ions (Kong and Jang, 2008). Some authors
have proposed that AgNPs form deposits on the microbial cell
wall and exert their toxic effects by inactivating essential
enzymes, for example by forming complexes with the catalytic
sulfur of thiol groups in cysteine residues (Feng et al., 2000),
and through the production of ROS such as superoxide
anions, hydrogen peroxide, and hydroxyl radicals, all of which
have potent bactericidal activity. In addition to their direct
bactericidal activity, nanoparticles are also known to disrupt
bioﬁlm formation (Kalishwaralal et al., 2010a). Soo-Hwan
et al. (2011) reported that S. aureus and E. coli treated with
AgNPs displayed many fragments indicative of membrane
damage on the cell surface. They also found that ROS were
responsible for increased permeability of the cell membrane
or leakage of cell contents. Liu et al. (2013) demonstrated that
silver nanoparticles embedded in titanium oxide (Ag–TiO2) are
an effective biocidal agent against microbes. Transmission
electron microscopy and electron energy-loss spectroscopy
indicated cellular damage after co-incubation with the nano-
composite, showing that Ag–TiO2 interaction with the bacte-
rial membrane led to leakage of ions that are critical for cell
survival, and strongly suggested that OH was at least partly
responsible for the ROS-mediated damage (Liu et al., 2013).
Morones-Ramirez et al. (2013) suggested that the increase
in ROS production is likely an indirect effect of the interaction
of silver with its targets. Another possible mechanism to
explain the enhanced antibacterial activity of antibiotics with
AgNPs is the bonding between nanoparticles and antibiotic
molecules. The active functional groups of antibiotics, such
as hydroxyl and amino groups, can be chelated by silver and
thereby cover a considerable portion of the surface of AgNPs
(Fayaz et al., 2010). Morones-Ramirez et al. (2013) proposed a
mechanism of silver-induced cell death in which silver disrupts
multiple bacterial cellular processes, including disulﬁde-bond
formation, metabolism, and iron homeostasis. These changes
lead to increased production of ROS and increased membrane
permeability of Gram-negative bacteria, both of which can
potentiate the activity of a broad range of antibiotics against
Gram-negative bacteria in different metabolic states, as well
as restore antibiotic susceptibility to a resistant bacterial strain.
4. Conclusion
In this work, a systematic methodology was designed to eluci-
date the enhanced effects of AgNPs with or without broad-
spectrum antibiotics. To this end, we synthesized signiﬁcantlyPlease cite this article in press as: Gurunathan, S. Rapid biological synthesis of si
fergusonii and Streptococcus mutans. Arabian Journal of Chemistry (2014), http://dhigh yields of AgNPs using an environmentally friendly bio-
chemical approach using supernatants from B. cereus cultures.
These AgNPs were then characterized using various analytical
techniques and found to be uniform in size, with an average
size of 10 nm. Furthermore, the antibacterial activity of the
selected antibiotics increased in the presence of AgNPs against
two bacterial test strains. The increase in activity was more
pronounced with gentamycin for E. fergusonii and with vanco-
mycin for S. mutans. Interestingly, the combination of sub-
lethal concentrations of antibiotics with AgNPs decreased
the cell viability and increased protein leakage and ROS gener-
ation, thus providing a possible mechanism for the enhanced
effects of antibiotics and AgNPs. Furthermore, these results
suggest that biologically synthesized AgNPs could be used as
an adjuvant for the treatment of various infectious diseases
caused by Gram-negative and Gram-positive bacteria. Thus,
our ﬁndings support the claim that AgNPs have considerable
antibacterial activity, which can be used to enhance the action
of existing antibiotics against Gram-negative and Gram-posi-
tive bacteria.
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